ACX

San Francisco, United States

ACX recreates synthetic compounds that bacteria uses to kill microbes for therapeutic development.

$500K raised

Sep 2024

Pre-Seed

Top Investors

Y Combinator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ACX raised?

ACX has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.

Who are ACX's investors?

ACX's investors include Y Combinator.

Where is ACX headquartered?

ACX is headquartered in San Francisco, United States.

What does ACX do?

ACX recreates synthetic compounds that bacteria uses to kill microbes for therapeutic development.

What stage is ACX at?

ACX is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2024.

MLA

"ACX — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/acx. Accessed June 8, 2026.

APA

VCBacked. (2024). ACX — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/acx

Wikipedia (cite web)

{{cite web |title=ACX — Funding & Investors |url=https://www.vcbacked.co/company/acx |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2024.